Views | |
---|---|
In Vivo Viral Control in a HLA-B*35:01 Homozygous Individual after the Vaccine-induced Response to a Well-defined, HIV Gag-derived HLA-B*35 CTL Epitope | 941 |
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
In Vivo Viral Control in a HLA-B*35:01 Homozygous Individual after the Vaccine-induced Response to a Well-defined, HIV Gag-derived HLA-B*35 CTL Epitope | 5 | 3 | 9 | 7 | 2 | 5 | 4 |
Views | |
---|---|
artconlli_a2014_brander_christian_vivo_viral_control.pdf | 909 |
artconlli_a2014_brander_christian_vivo_viral_control.pdf.txt | 5 |
Views | |
---|---|
United States | 592 |
China | 68 |
Russia | 56 |
Sweden | 42 |
Germany | 37 |
France | 32 |
Ukraine | 19 |
United Kingdom | 17 |
Spain | 10 |
Canada | 7 |
Views | |
---|---|
Ashburn | 154 |
Fairfield | 67 |
Sunnyvale | 58 |
Houston | 42 |
Ann Arbor | 39 |
Oakland | 29 |
Zhengzhou | 28 |
Saint Petersburg | 24 |
Cambridge | 20 |
Beijing | 17 |